NCT04430738 2026-02-24Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersSeagen Inc.Phase 2 Active not recruiting40 enrolled 67 charts
NCT04175912 2025-11-17Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the LiverNational Cancer Institute (NCI)Phase 2 Active not recruiting40 enrolled 11 charts